Alpha Tau Medical Ltd. (DRTS) Stock

Alpha Tau Medical Ltd. (DRTS) is a Healthcare stock trading at $9.77 (as of 2026-06-18), with a market capitalization of $953.15M and a trailing P/E of -18.6. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.

Alpha Tau Medical Ltd. is a clinical-stage oncology therapeutics company developing and commercializing diffusing alpha-emitters radiation therapy (Alpha DaRT). It pursues treatment of solid cancers through research and clinical trials for indications such as skin, oral, pancreatic, and breast cancer, with additional preclinical studies, in Israel and the United States.

Valuation — source: SEC EDGAR (first-party)
Price$9.77
Market Cap$953.15M
P/E Ratio-18.6
EV / EBITDA-20.8
Price / Book11.24
DCF Value (model)$-6.20
DCF Upside vs Price-163.5%
Profitability & Growth — source: SEC EDGAR
Return on Equity-55.3%
Debt / Equity0.00
Current Ratio7.45
Valuation vs Sector & Industry
Stock P/E-18.6
Sector P/E (Healthcare)21.0
Industry P/E (Medical Equipment)31.7
vs Sector-188.7%
vs Industry-158.5%
Smart-Money Activity — SEC Form 4 / 13F / Congressional disclosures
Top Institutional HolderHighTower Advisors, LLC ($6.19M)
Institutional Holders Tracked10
Company
SectorHealthcare
IndustryMedical Equipment
CEOUzi Sofer
Employees125
CountryIL
IPO Date2021-03-08

Related Companies (Business model: Medical Devices / Life Science Tools; 8 closest by market cap; US-domiciled)

  • CapsoVision, Inc. (CV)
  • OrthoPediatrics Corp. (KIDS)
  • Owlet, Inc. (OWLT)
  • RxSight, Inc. (RXST)
  • Sight Sciences, Inc. (SGHT)
  • AngioDynamics, Inc. (ANGO)
  • ClearPoint Neuro, Inc. (CLPT)
  • Cerus Corporation (CERS)
DRTS earnings history · DRTS institutional & insider holders · Congress trades · Insider trades · Short interest · Stock screener

Data as of 2026-06-18.

Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.